Shen Lian partners with Lanzhou Institute on livestock vaccines
Shanghai Shen Lian Biomedical Corporation announced a collaboration with the Lanzhou Veterinary Research Institute to develop multi-valent vaccines for livestock.
The joint project will focus on a triple vaccine for pigs and a triple vaccine for cattle, targeting multiple diseases including foot-and-mouth disease. The partnership aims to secure clinical trial approvals and new veterinary drug registration certificates, with intellectual property jointly owned.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Shanghai Shen Lian Biomedical Corporation publishes news
Free account required • Unsubscribe anytime